+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urinary Incontinence Drug"

From
Urinary Incontinence - Pipeline Review, H2 2020 - Product Thumbnail Image

Urinary Incontinence - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 80 Pages
  • Global
From
From
Urinary Incontinence Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Urinary Incontinence Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Loading Indicator

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers. Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more